Prudential Financial »

Candel Therapeutics shares owned by Prudential Financial

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Prudential Financial from 13F filings

Historical chart of Prudential Financial investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Prudential Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Prudential Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $113k 11k 10.30

More positions owned by Prudential Financial

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Dimensional Etf Trust Us Equi Mark Et (DFUS)
Pgim Etf Tr Aaa Clo Etf (PAAA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Pgim Etf Tr Pgim Ultra Sh B (PULS)
Ishares Tr Iboxx Inv Cp Et (LQD)
Micron Technology (MU)
Meta Platforms Cl A (META)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Prudential Financial

Top funds holding Candel Therapeutics

FMR
Rtw Investments
BlackRock
Acorn Capital Advisors
Portolan Capital Management
Saturn V Capital Management
Vanguard Capital Management
Geode Capital Management
Millennium Management
State Street Corporation
Halter Ferguson Financial
Northern Trust
Kennedy Capital Management
Vanguard Portfolio Management
Vanguard Fiduciary Trust

View all funds holding Candel Therapeutics